COVID-19 vaccines could become available for children younger than 5 by the end of February, the Washington Post first reported and a source familiar with the situation confirmed to Axios on Monday.
Between the lines: Pfizer's vaccine would initially be available as a two-dose regimen under this plan. But recent data has shown that two doses do not provide a strong enough immune response in all age groups — meaning a major goal of the plan would be to begin the multi-week vaccination process while data is gathered on a third dose.
